retatrutide 32 Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide Significantly Reduces Visceral Fat

If supply is tight, adoption slows

They may be great products for aging skin, he says, but its hard to champion them as targeting specifically the effects of the GLP-1s because we're still figuring out why the GLP-1s caused rapid facial aging in the first place. Isabel Burton is an established writer, editor, brand consultant, and all-around content person specializing in beauty, wellbeing, travel, fashion, and lifestyle

It acts as an intracellular antioxidant and promotes powerful anti-aging effects

Among patients with type 2 diabetes, the risk of NAION was increased by 4.28 times, while in those using the drug for weight management, the risk surged by 7.64 times

Zepbounds superior clinical profile further tilts the scales in its favor

For a broader overview, read our GLP-1 medication guide and GLP-1 tracker app guide